This is a SBIR Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Eascra Biotech, Inc., a small business. The $74,974 firm fixed price contract is for research into the potential of Janus Base Nanoparticles (JBNS) for combat injury rehabilitation and pain management. The research aims to enhance military medical response capabilities. The contract has an ultimate completion date of November 4, 2024.
Generated 2/3/25, 1:44 PM